Crescita Therapeutics Inc. (TSE:CTX – Get Free Report)’s stock price was up 15.2% on Monday . The company traded as high as C$0.53 and last traded at C$0.53. Approximately 20,500 shares were traded during trading, an increase of 23% from the average daily volume of 16,682 shares. The stock had previously closed at C$0.46.
Crescita Therapeutics Trading Up 1.9 %
The company has a quick ratio of 2.29, a current ratio of 3.59 and a debt-to-equity ratio of 6.32. The firm’s 50 day moving average is C$0.44 and its two-hundred day moving average is C$0.45. The stock has a market cap of C$10.30 million, a price-to-earnings ratio of -4.33 and a beta of 1.65.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
See Also
- Five stocks we like better than Crescita Therapeutics
- EV Stocks and How to Profit from Them
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Dividend Capture Strategy: What You Need to Know
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Are Penny Stocks a Good Fit for Your Portfolio?
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
